A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide

Published:2020-03-13 Issue:10 Volume:9 Page:3319-3327
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Matsumoto Koji¹^ORCID,Takahashi Masato²,Sato Kazuhiko³,Osaki Akihiko⁴,Takano Toshimi⁵,Naito Yoichi⁶^ORCID,Matsuura Kazuo⁷,Aogi Kenjiro⁸,Fujiwara Kimiko⁹,Tamura Kenji¹⁰,Baba Motoi¹¹,Tokunaga Shinya¹²,Hirano Gen¹³,Imoto Shigeru¹⁴,Miyazaki Chieko¹⁵,Yanagihara Kazuhiro¹⁶,Imamura Chiyo K.¹⁷,Chiba Yasutaka⁹,Saeki Toshiaki⁴^ORCID

Affiliation:

1. Hyogo Cancer Center Hyogo Japan

2. NHO Hokkaido Cancer Center Hokkaido Japan

3. Tokyo‐West Tokushukai Hospital Tokyo Japan

4. Saitama Medical University Saitama Japan

5. Toranomon Hospital Tokyo Japan

6. National Cancer Center Hospital East Kashiwa Japan

7. Hiroshima Prefectural Hospital Hiroshima Japan

8. Shikoku Cancer Center Ehime Japan

9. Kindai University Hospital Osaka Japan

10. National Cancer Center Hospital Tokyo Japan

11. Hokkaido University Hokkaido Japan

12. Osaka City General Hospital Osaka Japan

13. Kyushu Hospital Fukuoka Japan

14. Kyorin University Tokyo Japan

15. Jichi Medical University Tochigi Japan

16. Kansai Electric Power Hospital Osaka Japan

17. Advanced Cancer Translational Research Institute Showa University Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2979

Reference21 articles.

1. Antiemetics: American Society of Clinical Oncology Focused Guideline Update

2. Network NCC. NCCN Cliincal Practice Guidlines in Oncology Antiemesis.2012.

3. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

4. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

5. A Systematic Review and Meta-Analysis of Intravenous Palonosetron in the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B);Annals of Oncology;2024-09

2. Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study;International Journal of Clinical Oncology;2024-08-18

3. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26

4. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting;ESMO Open;2024-02

5. 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents;Supportive Care in Cancer;2023-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3